Vortioxetine for the Treatment of Major Depression and Co-morbidities After Traumatic Brain Injury (TBI)

NCT02845349 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding withdrawn.

Conditions

TBI
Major Depression

Interventions

DRUG: Vortioxetine
DRUG: Placebo

Sponsor

Johns Hopkins University

Collaborators

[object Object]